UP!

AIXG $3.06

AIXG target price
3.06
0
0
AIXTRON SE
Type
Societas Europaea
Traded as FWB: AIXA,
OTC Market: AIXNY
Industry Semiconductor industry
Founded 1983
Headquarters Herzogenrath, Germany
Key people
Kim Schindelhauer (CEO), Prof. Dr. Wolfgang Blättchen (Chairman of the supervisory board)
Products Metalorganic chemical vapour deposition equipment
Revenue €196.5 million (2016)
Operating income
€-21.4 million (2016)
Profit €-24.0 million (2016)
Total assets €436.2 million (end 2016)
Total equity €369.7 million (end 2016)
Number of employees
705 (end 2016)
Website www.aixtron.com

AIXTRON SE is a German-based technology company, which specialises in manufacturing metalorganic chemical vapour deposition (MOCVD) equipment, for clients in the semiconductor industry. The company's shares are listed on the Frankfurt Stock Exchange and are currently traded in the OTC market. Until December 19, 2016 AIXTRON used to be a constituent of the TecDAX index. AIXTRON returned to the German technology index as per March 20, 2017.

AIXTRON was founded as a spin-out industry from RWTH Aachen University in 1983. The company listed on the Frankfurt Stock Exchange's now-defunct Neuer Markt, in November 1997. Since going public the company has made several acquisitions, with the Scientific Equipment Division of the British company Thomas Swan & Co. and the Swedish chemical vapor deposition equipment maker Epigress AB both purchased in 1999.

The company completed a €118 million merger with American rival Genus, Inc. in March 2005 and bought British nanomaterial developer Nanoinstruments Ltd., a company spun out from the University of Cambridge, in 2007.

In December 2010 the company converted from a German Aktiengesellschaft to a Societas Europaea to reflect its European and international nature.

In October 2016 China’s Fujian Grand Chip Investment Fund LP wanted to acquire Aixtron, but Germany’s economics ministry withdrew the approval of the takeover. In November 2016 the Committee on Foreign Investment in the United States (CFIUS) recommended both sides to drop their plan, because of national security concerns.

In 2017 Aixtron sold its ALD/CVD Memory Product line produced in Sunnyvale to Eugene Technology from South Korea. The US business was the reason CFIUS had US national security conserns. Aixtron said it continues to execute restructuring measures as well as to seek the establishment of partnerships for its OLED business in order to return to profitability in 2018.

65% of AIXTRON's revenues come from clients in Asia, with around 16% coming from Europe and the remaining 19% from the United States. The company produces metalorganic chemical vapour deposition equipment, used for making a range of electronic and opto-electronic products containing compound, organic and silicon-based semiconductors as well as nanotubes and nanofibers.

Many AIXTRON systems use a "planetary reactor" process whereby gaseous semiconductor substances are deposited on revolving wafers, while others utilise a Close Coupled "shower head" method of deposition.

Manufacturing sites are located in Herzogenrath near Aachen in Germany, Cambridge in the United Kingdom, and Sunnyvale, California, United States.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-06-29 Reiterated Rating DZ Bank AG Sell
2016-05-24 Upgrade Commerzbank AG Reduce to Hold
2016-05-24 Reiterated Rating Canaccord Genuity Sell
2016-05-23 Reiterated Rating DZ Bank AG Sell
2016-04-26 Reiterated Rating DZ Bank AG Sell
2016-04-26 Reiterated Rating Canaccord Genuity Sell
2016-04-21 Reiterated Rating Equinet Institutional Services Buy
2016-04-15 Reiterated Rating DZ Bank AG Sell
2016-02-23 Reiterated Rating Canaccord Genuity Sell $3.00
2016-01-20 Reiterated Rating DZ Bank AG Neutral
2015-12-18 Downgrade Morgan Stanley Overweight to Equal Weight
2015-12-15 Downgrade Barclays Overweight to Equal Weight
2015-12-15 Downgrade Barclays PLC Overweight to Equal Weight
2015-12-11 Downgrade Bankhaus Lampe Hold
2015-12-10 Lower Price Target Canaccord Genuity Sell $4.50 to $3.75
2015-12-10 Reiterated Rating DZ Bank AG Neutral
2015-12-10 Downgrade Benchmark Co. Positive
2015-12-04 Downgrade CLSA Underperform to Sell
2015-12-04 Downgrade Credit Agricole Underperform to Sell
2015-12-04 Downgrade Credit Agricole SA Underperform to Sell
2015-11-23 Downgrade JPMorgan Chase & Co. Overweight to Neutral
2015-11-17 Boost Price Target Barclays $5.00 to $10.00
2015-11-16 Upgrade Barclays Equal Weight to Overweight $5.00 to $10.00
2015-10-28 Upgrade Kepler Capital Markets Sell to Hold
2015-10-27 Reiterated Rating Canaccord Genuity Sell $4.50
2015-10-27 Reiterated Rating DZ Bank AG Buy
2015-10-15 Reiterated Rating Oppenheimer Market Perform
2015-10-15 Reiterated Rating Northland Securities Market Perform
2015-10-15 Reiterated Rating Oppenheimer Holdings Inc. Market Perform
2015-10-14 Reiterated Rating Canaccord Genuity Sell $4.50
2015-10-13 Reiterated Rating DZ Bank AG Buy
2015-07-31 Upgrade BNP Paribas Neutral to Outperform
2015-07-29 Reiterated Rating Oppenheimer Market Perform
2015-07-29 Lower Price Target Canaccord Genuity Sell $5.60 to $4.50
2015-07-28 Reiterated Rating Canaccord Genuity Sell $5.60
2015-07-09 Downgrade Kepler Capital Markets Hold to Reduce
2015-04-28 Reiterated Rating Canaccord Genuity Sell $6.50
2015-04-23 Downgrade Equinet Institutional Services Neutral
2015-04-08 Downgrade Berenberg Bank Buy to Hold
2015-02-24 Reiterated Rating Canaccord Genuity Sell $6.00
2015-02-20 Upgrade Societe Generale Sell to Hold
2014-10-29 Reiterated Rating Canaccord Genuity Sell $7.00 to $6.00
2014-09-26 Upgrade Equinet Institutional Services Sell to Buy
2014-09-26 Upgrade Morgan Stanley Equal Weight to Overweight
2014-09-19 Reiterated Rating Berenberg Bank Hold to Buy
2014-05-28 Upgrade DZ Bank AG Sell to Hold
2014-04-24 Upgrade HSBC Underweight to Neutral
2014-03-11 Downgrade BNP Paribas Outperform to Neutral
2014-02-26 Lower Price Target Canaccord Genuity $8.00 to $7.00
2014-02-24 Downgrade Hauck & Aufhaeuser Buy to Hold
2014-02-24 Upgrade Commerzbank AG Hold to Buy
2014-02-18 Upgrade JPMorgan Chase & Co. Neutral to Overweight
2014-01-17 Downgrade Natixis Buy to Neutral
2013-10-28 Boost Price Target Canaccord Genuity Sell $7.00 to $8.00
2013-10-22 Lower Price Target Goldman Sachs Neutral $17.00 to $14.00
2013-10-21 Downgrade Deutsche Bank Buy to Hold
2013-10-10 Downgrade HSBC Securities Neutral to Underweight
2013-10-10 Downgrade HSBC Neutral to Underweight
2013-10-01 Downgrade Canaccord Genuity Hold to Sell $13.00 to $7.00
2013-04-26 Upgrade Northland Capital Under Perform to Market Perform $13
2013-01-14 Reiterated Canaccord Genuity Sell $9 to $11
2012-08-01 Upgrade HSBC Securities Underweight to Neutral
2012-03-05 Upgrade Canaccord Genuity Sell to Hold $15
2011-12-15 Initiated Maxim Group Sell $8
2011-10-21 Downgrade Kaufman Bros Buy to Hold $22 to $14
2011-10-17 Reiterated Canaccord Genuity Sell $23 to $8
2011-09-29 Reiterated Kaufman Bros Buy $37 to $22
2011-09-19 Downgrade HSBC Securities Overweight to Neutral
2011-07-19 Upgrade Kaufman Bros Hold to Buy $40
2011-07-11 Reiterated Barclays Capital Equal Weight $40 to $28
2011-04-28 Reiterated Kaufman Bros Hold $42 to $40
2011-04-25 Reiterated Barclays Capital Equal Weight $45 to $40
2011-03-02 Reiterated Kaufman Bros Hold $37 to $42
2011-02-07 Reiterated Barclays Capital Equal Weight $32 to $45
2010-12-14 Downgrade Kaufman Bros Buy to Hold $37 to $37
2016-06-29 Reiterated Rating DZ Bank AG Sell
2016-05-24 Upgrade Commerzbank AG Reduce to Hold
2016-05-24 Reiterated Rating Canaccord Genuity Sell
2016-05-23 Reiterated Rating DZ Bank AG Sell
2016-04-26 Reiterated Rating DZ Bank AG Sell

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In AIXG 3 funds of 2213 total. Show all

Fund name Ticker shares
Empire Capital Management, L.L.C. 100000
Dynamic Technology Lab Pte Ltd 18225
FIRST NEW YORK SECURITIES LLC /NY 1000

Major Shareholders

Name Relationship Total Shares Holding stocks